alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 31.1****CERTIFICATION PURSUANT TO SECTION 302 (a) OF THE SARBANES-OXLEY ACT**I, Jack H. Brown, certify that:1. I have reviewed this report on Form 10-Q of Stater Bros. Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officers and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: a) Designed such disclosure controls and procedures, or caused such disclosure controlsand procedures to be designed under our supervision, to ensure that material informationrelating to the registrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which this report is beingprepared;  b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controlsand procedures, as of the end of the period covered by this report based on suchevaluation; and  c) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and5. The registrant’s other certifying officers and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing the equivalentfunctions): a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information;and  b) Any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.     Date: February 7, 2007         /s/ Jack H. Brown     Jack H. Brown    Chairman of the Board, President,    and Chief Executive Officer    (Principal Executive Officer)
Exhibit 32

# Certification Pursuant to 18. U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly
report of Gibraltar Packaging Group, Inc. (the Company) on Form 10-Q for the
quarter ended December 31, 2003 as filed with the Securities and Exchange Commission on
the date hereof (the Report), the undersigned, being the Chief Executive
Officer and the Vice President Finance (chief financial officer), respectively, of the
Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of
the Sarbanes-Oxley Act of 2002, that:

|(1) |  | The Report fully complies with the requirements of § 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
|--- |  | ---------------------------------------------------------------------------------------------------------------

|(2) |  | The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------

|/s/   Walter E. Rose        |  | /s/   Brett E. Moller  | 
|--------------------------- |  | ---------------------- | 
|                            |  |                        | 
|WALTER E. ROSE              |  | BRETT E. MOLLER        | 
|Chairman of the Board       |  | Vice President Finance | 
|and Chief Executive Officer | 

Dated:   February 13, 2004

This certification is made solely for
the purpose of 18 U.S.C. § 1350, subject to the knowledge standard contained in that
statute, and not for any other purpose.

---
<TABLE> <S> <C>


<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                       2,524,259
<SECURITIES>                                         0
<RECEIVABLES>                                6,547,960
<ALLOWANCES>                                  (179,664)
<INVENTORY>                                          0
<CURRENT-ASSETS>                            26,256,837
<PP&E>                                       3,536,220
<DEPRECIATION>                                (463,701)
<TOTAL-ASSETS>                              36,804,495
<CURRENT-LIABILITIES>                       16,202,092
<BONDS>                                        731,347
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       117,929
<OTHER-SE>                                  19,671,740
<TOTAL-LIABILITY-AND-EQUITY>                36,804,495
<SALES>                                     45,831,932
<TOTAL-REVENUES>                            45,831,932
<CGS>                                       38,317,499
<TOTAL-COSTS>                               38,317,499
<OTHER-EXPENSES>                             6,179,618
<LOSS-PROVISION>                              (179,664)
<INTEREST-EXPENSE>                           1,121,724
<INCOME-PRETAX>                             10,934,092
<INCOME-TAX>                                 3,101,892
<INCOME-CONTINUING>                          7,832,200
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 7,810,813
<EPS-BASIC>                                       1.21
<EPS-DILUTED>                                     1.21



</TABLE>
EXHIBIT 32

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Garb Oil & Power Corporation, and subsidiaries (the “Company”) on Form 10-KSB/A for the fiscal year ending June 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John C. Brewer, Chief Executive Officer and Chief Financial Officer of the Company certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

|   | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of |
|--------|-----|------------------------------------------------------------------------------|

the Securities Exchange Act of 1934; and

 

|   | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------|

 

 

| Date: 11/14/2008            |
|-----------------------------|
|                        |
| By: /s/ John C. Brewer      |
| John C. Brewer              |
| Chief Executive Officer and |
| Chief Financial Officer     |

 

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 27 Referred in Senate (RFS)]

<DOC>
117th CONGRESS
  1st Session
H. J. RES. 27

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 20, 2021

    Received; read twice and referred to the Committee on Rules and 
                             Administration

_______________________________________________________________________

                            JOINT RESOLUTION

 
Providing for the appointment of Barbara Barrett as a citizen regent of 
          the Board of Regents of the Smithsonian Institution.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, That, in accordance with 
section 5581 of the Revised Statutes (20 U.S.C. 43), the vacancy on the 
Board of

              

 Regents of the Smithsonian Institution, in the class other than 
Members of Congress, occurring by reason of the expiration of the term 
of David M. Rubenstein of Maryland on May 7, 2021, is filled by the 
appointment of Barbara M. Barrett of Arizona. The appointment is for a 
term of 1,912 days, beginning on May 8, 2021, or the date of the 
enactment of this joint resolution, whichever occurs later.

            Passed the House of Representatives May 20, 2021.

            Attest:

                                             CHERYL L. JOHNSON,

                                                                 Clerk.
```
exhibit10-39.htm


    
      Exhibit
10.39

      


      


      


      January
14, 2009

      


      Alnoor
Shivji

      Chairman,
President and Chief Executive Officer

      WaferGen
Bio-systems, Inc.

      


      Re:           Salary
Adjustment

      


      Dear
Alnoor:

      


      Per our
agreement on November 1, 2008, your base salary was reduced from $5,048 per week
($262,500 annualized) to $4,290 per week, effective November 1,
2008.  Please sign below to confirm your agreement to these salary
adjustments.

      


      WaferGen
Bio-Systems, Inc. (“WaferGen”) will increase your base salary to the rate of
$262,500 per year in the event it (a) raises $5 million in gross proceeds from
the sale of its securities in one or more financings on or prior to March 30,
2009, excluding any gross proceeds received in connection with any financings
completed by its subsidiary, WaferGen Biosystems (M) Sd. Bhd., a Malaysian
corporation; or (b) raises after March 30, 2009 funds sufficient to finance
WaferGen’s operations at its then-current burn rate for an additional nine
months after the closing of such financing, as reasonably determined by the
compensation committee of the board of directors of WaferGen.  Such
salary increase would be documented in a written agreement to be signed by the
Company and you.

      


      All other
terms of your Executive Employment Agreement dated May 31, 2007 will remain in
full force and effect, including the severance provisions in Section
10.  In the event you become eligible for severance under Section 10
of your Executive Employment Agreement, your severance will be calculated based
on a salary rate of $262,500 per year.  You acknowledge and agree that
you are waiving any right you may have to terminate your employment for “Good
Reason” under Section 10(e) of your Executive Employment Agreement with respect
to this one-time salary reduction as described above.

      


      We
appreciate your continuing support and contributions to WaferGen during these
challenging times for our industry.

      


                                                              Very truly
yours,

      


                                                              /s/ Joel
Kanter


                                                              Joel
Kanter

                                                              Chairman of Audit
Committee

      


      ACCEPTED
AND AGREED:

      


      Dated:  January
16,
2009                                                    /s/ Alnoor Shivji

                                                              Alnoor
Shivji
#### People v Isaac Gibbs,

No. 91091;

Court of Appeals No. 127643.
EX PARTE K.W.B.

(In re: K.W.B. v. B.O.B.)

2160388

Court of Civil Appeals of Alabama.

March 13, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Mand. pet. denied.
John Jeffery WRIGHT, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-2838

District Court of Appeal of Florida, Fifth District.

Decision filed December 26, 2017

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Jeffrey Lance HILL, Sr., Appellant, v. SUWANNEE RIVER WATER MANAGEMENT DISTRICT, Appellee.

No. 1D17-1691

District Court of Appeal of Florida, First District.

February 14, 2018 Rehearing Denied March 27, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
#### STATE of Arkansas *v.*Randall L. WILLIAMS, Judge

CR 74-23

512 S.W. 2d 531

Opinion delivered June 24, 1974

[Rehearing denied September 9, 1974.]

*Jim Guy Tucker,*Atty. Gen., by: *Alston Jennings Jr.,*Asst. Atty. Gen., for petitioner.

*George Howard Jr.,*for respondent.

George Rose Smith, Justice.

This is an *ex parte*petition Tiled by the State of Arkansas for a writ of certiorari to quash an order entered in the Jefferson Circuit Court in the case of *Jackson*v. *State.*Curtis Lee Jackson, who appears to be the real party in interest, has appeared specially by counsel to ask that the petition for a writ of certiorari be dismissed. Upon the six-page record before us we conclude that the petition should be dismissed, for want of proper parties.

In March, 1973, we affirmed a judgment finding Jackson guilty of burglary and sentencing 'him to imprisonment for two years. *Jackson*v. *State,*253 Ark. 1116, 491 S.W. 2d 581 (1973). In September the trial court, at Jackson’s request, entered an order suspending the sentence and allowing him to remain at liberty, without supervision. Apparently the State filed a notice of appeal from that order, but we infer from the record that the appeal was not perfected owing to the State’s failure to obtain the record and lodge it in this court.

On February 14, 1974, the Attorney General filed the *795present *ex parte*petition for a writ of certiorari to quash the trial court’s order of suspension, the State’s contention apparently being that the order is void under such cases as *Freeman*v. *State,*158 Ark. 262, 249 S.W. 582, 250 S.W. 522 (1923). Jackson is obviously the real party in interest, but, as we have indicated, he is >not joined as a party to the proceeding and appears specially to oppose the petition.

We are unwilling to say that the trial court’s order of suspension is so demonstrably void on its face that it should be quashed in a proceeding to which Jackson, the person actually concerned, is not a party. Ordinarily a petition for cer-tiorari is an adversary proceeding, in which interested persons are entitled to be heard. See *Black*v. *Brinkley,*54 Ark. 372, 15 S.W. 1030 (1891). Here it is certainly possible that Jackson has a valid defense to the petition, or at least an arguable one. There is, for example the possibility that the State consented to the order or that its abortive attempt to appeal precludes it from attacking the order. What the State is asking us to do, in this *ex parte*proceeding, is to cancel the trial court’s order and to send Jackson to prison, without affording him either notice or an opportunity to be heard, and with no evidence except the bare order itself. We are not persuaded that such a summary disposition of the matter is called for.

Petition dismissed.
Amendment No. 1 to Warrant to Purchase Stock Agreement, dated February 19, 2009



 Exhibit 4.6 
 AMENDMENT NO. 1 TO WARRANT 
 TO 
 PURCHASE STOCK 
 THIS
AMENDMENT NO. 1 TO WARRANT TO PURCHASE STOCK (this “Amendment”) is entered into as of the 19th day of February 2009, by and between
ARCA biopharma, Inc., a Delaware corporation (f/k/a Nuvelo, Inc.) and SVB Financial Group. 
 Recitals 
 A. The Holder was previously issued a Warrant to Purchase Stock dated as of August 19, 2008 (the “Warrant”). Capitalized terms used in this
Amendment, but not otherwise defined in this Amendment, shall have the meanings assigned to them in the Warrant. 
 B. Dawn Acquisition Sub, Inc., a Delaware
corporation and wholly-owned subsidiary of ARCA biopharma, Inc., a Delaware corporation (f/k/a Nuvelo, Inc.), was merged with and into ARCA biopharma Colorado, Inc., a Delaware corporation (f/k/a ARCA biopharma, Inc.) (the
“Merger”). 
 C. The Holder and ARCA biopharma, Inc., a Delaware corporation (f/k/a Nuvelo, Inc.) desire to amend the Warrant to reflect the
closing of the Merger, the exchange of the common stock of the Company (as defined below) for the common stock of ARCA biopharma Colorado, Inc., a Delaware corporation (f/k/a ARCA biopharma, Inc.) and assumption of the Warrant as required by
Section 1.6.2(d) of the Warrant in connection with the closing of the Merger. 
 Amendments 
 1. The Warrant Price shall be $19.48 per share, subject to adjustment after the date of this Amendment in accordance with the terms of the Warrant. 
 2. The Number of Shares shall be 6,679, subject to adjustment after the date of this Amendment in accordance with the terms of the Warrant. 
 3. The Class of Stock shall be the common stock, $0.001 par value per share, of the Company. 
 4. The Company shall be ARCA biopharma, Inc., a Delaware corporation (f/k/a Nuvelo, Inc.). 
 5. Except for revisions
expressly set forth in this Amendment, the parties hereby ratify and confirm the terms of the Warrant in their entirety. 







 IN WITNESS WHEREOF, the undersigned have executed this Amendment to be effective as of the date first set
forth above. 
  

									
	Company:	 		 	Holder:
			
	ARCA BIOPHARMA, INC.	 		 	SVB FINANCIAL GROUP
					
	By:	 	 /s/ Christopher D. Ozeroff
	 		 	By:	 	 /s/ Norman Cutler

		 	Christopher D. Ozeroff, Executive Vice of Business Development and General Counsel	 		 	Print Name:	 	 Norman Cutler

		 	 		 	Title:	 	 Derivatives Manager
117TH CONGRESS 

1ST SESSION H. R. 1002 

AN ACT 

To amend the Controlled Substances Act to authorize the 

debarment of certain registrants, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 1002 EH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Debarment Enforce3 ment of Bad Actor Registrants Act of 2021’’ or the 

4 ‘‘DEBAR Act of 2021’’. 

5 SEC. 2. DEBARMENT OF CERTAIN REGISTRANTS. 

6 Section 304 of the Controlled Substances Act (21 

7 U.S.C. 824) is amended by adding at the end the fol8 lowing: 

9 ‘‘(h) The Attorney General may issue an order to pro10 hibit, conditionally or unconditionally, and permanently or 

11 for such period as the Attorney General may determine, 

12 any person from being registered under this title to manu13 facture, distribute, or dispense a controlled substance or 

14 a list I chemical, if the Attorney General finds that— 

15 ‘‘(1) such person meets or has met any of the 

16 conditions for suspension or revocation of registra17 tion under subsection (a); and 

18 ‘‘(2) such person has a history of prior suspen19 sions or revocations of registration.’’. 

20 SEC. 3. DETERMINATION OF BUDGETARY EFFECTS. 

21 The budgetary effects of this Act, for the purpose of 

22 complying with the Statutory Pay-As-You-Go Act of 2010, 

23 shall be determined by reference to the latest statement 

24 titled ‘‘Budgetary Effects of PAYGO Legislation’’ for this 

25 Act, submitted for printing in the Congressional Record 

26 by the Chairman of the House Budget Committee, pro-
3 

•HR 1002 EH

1 vided that such statement has been submitted prior to the 

2 vote on passage. 

Passed the House of Representatives April 15, 2021. 

Attest: 

Clerk. 
117TH CONGRESS 

1ST SESSION H. R. 1002 

AN ACT 

To amend the Controlled Substances Act to authorother purposes. ize the debarment of certain registrants, and for
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<RESTATED> 
<CIK> 0000882100
<NAME> CORVAS INTERNATIONAL, INC.
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                           3,541
<SECURITIES>                                    16,933
<RECEIVABLES>                                      411
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                21,239
<PP&E>                                           5,258
<DEPRECIATION>                                   3,596
<TOTAL-ASSETS>                                  22,901
<CURRENT-LIABILITIES>                            3,871
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          1
<COMMON>                                            14
<OTHER-SE>                                      19,015
<TOTAL-LIABILITY-AND-EQUITY>                    22,901
<SALES>                                             44
<TOTAL-REVENUES>                                 5,632
<CGS>                                               18
<TOTAL-COSTS>                                    9,966
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (3,757)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (3,757)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,757)
<EPS-PRIMARY>                                    (.27)
<EPS-DILUTED>                                    (.27)
        

</TABLE>
UNITED STATES DISTRICT COURT

SOUTHERN DISTRICT OF OHIO

EASTERN DIVISION

Rico Isaih Halrston,

Plaintiff, Case No. 2:18-cv-826

V. Judge Michael H. Watson

Shelble Smith, et al., Magistrate Judge Vascura

Defendants.

ORDER

Magistrate Judge Vascura Issued an Order and Report and

Recommendation ("R&R") on September 25, 2018, granting Plaintiff leave to

proceed in forma pauperls and recommending the Court dismiss this action for

failure to state a claim and deny as moot PlaintifTs motion for a temporary

restraining order ("TRO"), EOF No. 2, and motion for the Clerk to make service

copies, ECF No. 3. R&R, ECF No. 12. The R&R recommends dismissing the

due process claims relating to Plaintiffs confinement in segregation and alleged

violations of state administrative regulations and policies as well as his claims

relating to asbestos and mold exposure without prejudice to continuing to

prosecute those claims in case number 2:18-CV-378. /d. at 7-8. The R&R

recommends dismissing PlaintifTs due process claim relating to his increased

security level and equal protection claims with prejudice. Id. at 8.

The R&R advised Plaintiff of his right to object to the same and of the

consequences for failing to do so. Id. at 11. Specifically, it warned Plaintiff that
the failure to object to the R&R would result in a waiver of the right to de novo

review of the R&R as well as a waiver of the right to appeal the Undersigned's

adoption of the R&R. Id. The time for filing objections has passed, and none

were filed. Accordingly, the Court ADOPTS the R&R and DISMISSES this case

pursuant to the recommendations contained therein.

IT IS SO ORDERED.

IICHAEL H. WATSON, JUDGE

UNITED STATES DISTRICT COURT